BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Colorectal cancer AND SMAD4, JIP, Q13485, 4089, ENSG00000141646, MADH4, DPC4 AND Prognosis
100 results:

  • 1. Clinical and genetic factors associated with tumor response to neoadjuvant (chemo)radiotherapy, survival and recurrence risk in rectal cancer.
    Hammarström K; Nunes L; Mathot L; Mezheyeuski A; Lundin E; Korsavidou Hult N; Imam I; Osterlund E; Sjöblom T; Glimelius B
    Int J Cancer; 2024 Jul; 155(1):40-53. PubMed ID: 38376070
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Integrating cfDNA liquid biopsy and organoid-based drug screening reveals PI3K signaling as a promising therapeutic target in colorectal cancer.
    Yang H; Xiao X; Zeng L; Zeng H; Zheng Y; Wang J; Li G; Dai W; He Y; Wang S; Peng J; Chen W
    J Transl Med; 2024 Feb; 22(1):132. PubMed ID: 38310289
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. TIF1γ and smad4 regulation in colorectal cancer: impact on cell proliferation and liver metastasis.
    Wu Y; Yu B; Ai X; Zhang W; Chen W; Laurence A; Zhang M; Chen Q; Shao Y; Zhang B
    Biol Chem; 2024 Apr; 405(4):241-256. PubMed ID: 38270141
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. To Assess the Role of microRNA-451 in the Progression and Metastasis of colorectal cancer.
    Chen H; Yao J; Shan Z; Wei Y; You S; Li D; Zhang Y
    Appl Biochem Biotechnol; 2024 Feb; 196(2):1044-1057. PubMed ID: 37318687
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. Oncomicrobial Community Profiling Identifies Clinicomolecular and Prognostic Subtypes of colorectal cancer.
    Mouradov D; Greenfield P; Li S; In EJ; Storey C; Sakthianandeswaren A; Georgeson P; Buchanan DD; Ward RL; Hawkins NJ; Skinner I; Jones IT; Gibbs P; Ma C; Liew YJ; Fung KYC; Sieber OM
    Gastroenterology; 2023 Jul; 165(1):104-120. PubMed ID: 36933623
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. RNA-Interference-Mediated miR-122-Based Gene Regulation in Colon cancer, a Structural In Silico Analysis.
    Ganesan H; Nandy SK; Banerjee A; Pathak S; Zhang H; Sun XF
    Int J Mol Sci; 2022 Dec; 23(23):. PubMed ID: 36499586
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. Gene interaction perturbation network deciphers a high-resolution taxonomy in colorectal cancer.
    Liu Z; Weng S; Dang Q; Xu H; Ren Y; Guo C; Xing Z; Sun Z; Han X
    Elife; 2022 Nov; 11():. PubMed ID: 36345721
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. prognosis prediction of stage IV colorectal cancer patients by mRNA transcriptional profile.
    Wu B; Yang J; Qin Z; Yang H; Shao J; Shang Y
    Cancer Med; 2022 Dec; 11(24):4900-4912. PubMed ID: 35587572
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. TGF-β-Induced FLRT3 Attenuation Is Essential for cancer-Associated Fibroblast-Mediated Epithelial-Mesenchymal Transition in colorectal cancer.
    Yang M; Li D; Jiang Z; Li C; Ji S; Sun J; Chang Y; Ruan S; Wang Z; Liang R; Dai X; Li B; Zhao H
    Mol Cancer Res; 2022 Aug; 20(8):1247-1259. PubMed ID: 35560224
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. Use of Cabozantinib to Treat MET -amplified Pediatric colorectal cancer.
    Fukui S; Umeda K; Kubota H; Iwai A; Akazawa R; Isobe K; Tanaka K; Kouzuki K; Kawabata N; Saida S; Kato I; Hiramatsu H; Itatani Y; Funakoshi T; Adachi S; Takita J
    J Pediatr Hematol Oncol; 2023 Apr; 45(3):e423-e426. PubMed ID: 35536994
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. Genomic Landscape of Primary Tumor Site and Clinical Outcome for Patients with Metastatic colorectal cancer Receiving Standard-of-Care Chemotherapy.
    Mizukami T; Takahashi M; Sunakawa Y; Yuki S; Kagawa Y; Takashima A; Kato K; Hara H; Denda T; Yamamoto Y; Shiozawa M; Oki E; Okamoto W; Yoshino T; Eguchi Nakajima T
    Target Oncol; 2022 May; 17(3):343-353. PubMed ID: 35524872
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. A linkage between effectual genes in progression of CRC through canonical and non-canonical TGF-β signaling pathways.
    Shirin M; Madadi S; Peyravian N; Pezeshkian Z; Rejali L; Hosseini M; Moradi A; Khanabadi B; Sherkat G; Aghdaei HA; Nazemalhosseini-Mojarad E
    Med Oncol; 2022 Jan; 39(4):40. PubMed ID: 35092502
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. Neither Surgical Margin Status nor Somatic Mutation Predicts Local Recurrence After R0-intent Resection for colorectal Liver Metastases.
    Nishioka Y; Paez-Arango N; Boettcher FO; Kawaguchi Y; Newhook TE; Chun YS; Tzeng CD; Tran Cao HS; Lee JE; Vreeland TJ; Vauthey JN
    J Gastrointest Surg; 2022 Apr; 26(4):791-801. PubMed ID: 34725784
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. smad4 is critical in suppression of BRAF-V600E serrated tumorigenesis.
    Tong K; Kothari OA; Haro KS; Panda A; Bandari MM; Carrick JN; Hur JJ; Zhang L; Chan CS; Xing J; Gatza ML; Ganesan S; Verzi MP
    Oncogene; 2021 Oct; 40(41):6034-6048. PubMed ID: 34453124
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. Clinicopathological and Molecular Characteristics of colorectal Signet Ring Cell Carcinoma: A Review.
    An Y; Zhou J; Lin G; Wu H; Cong L; Li Y; Qiu X; Shi W
    Pathol Oncol Res; 2021; 27():1609859. PubMed ID: 34381313
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. Prognostic role and clinicopathological features of smad4 gene mutation in colorectal cancer: a systematic review and meta-analysis.
    Fang T; Liang T; Wang Y; Wu H; Liu S; Xie L; Liang J; Wang C; Tan Y
    BMC Gastroenterol; 2021 Jul; 21(1):297. PubMed ID: 34301194
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. Chromosome 20q11.21 Amplifications in colorectal cancer.
    Voutsadakis IA
    Cancer Genomics Proteomics; 2021; 18(3 Suppl):487-496. PubMed ID: 33994370
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. Enhancing the landscape of colorectal cancer using targeted deep sequencing.
    Lee CS; Song IH; Lee A; Kang J; Lee YS; Lee IK; Song YS; Lee SH
    Sci Rep; 2021 Apr; 11(1):8154. PubMed ID: 33854094
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. Black Raspberries Suppress colorectal cancer by Enhancing smad4 Expression in Colonic Epithelium and Natural Killer Cells.
    Huang YW; Lin CW; Pan P; Shan T; Echeveste CE; Mo YY; Wang HT; Aldakkak M; Tsai S; Oshima K; Yearsley M; Xiao J; Cao H; Sun C; Du M; Bai W; Yu J; Wang LS
    Front Immunol; 2020; 11():570683. PubMed ID: 33424832
    [TBL] [Abstract] [Full Text] [Related]  

  • 20. Characterization of genomic alterations in Chinese colorectal cancer patients.
    Huang W; Li H; Shi X; Lin M; Liao C; Zhang S; Shi W; Zhang L; Zhang X; Gan J
    Jpn J Clin Oncol; 2021 Jan; 51(1):120-129. PubMed ID: 33106877
    [TBL] [Abstract] [Full Text] [Related]  


    [Next]

    of 5.